60 Degrees Pharmaceuticals (SXTP) Finished Goods (2023 - 2025)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Finished Goods of $208195.0 for Q2 2025, up 74.99% year-over-year from $118973.0 in Q2 2024, and up 45.43% quarter-over-quarter from $143161.0 in Q1 2025.
60 Degrees Pharmaceuticals (SXTP) Finished Goods (2023 - 2025) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Finished Goods for 3 consecutive years, with $208195.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Finished Goods rose 74.99% year-over-year to $208195.0; the TTM figure through Jun 2025 stood at $208195.0 (up 74.99% YoY), while the FY2024 annual figure was $157881.0, down 15.65% from the prior year.
- Finished Goods grew to $208195.0 in Q2 2025 per SXTP's latest filing, from $143161.0 in the prior quarter.
- Across five years, Finished Goods topped out at $208195.0 in Q2 2025 and bottomed at $84449.0 in Q3 2024.
- Historically, Finished Goods has averaged $150890.1 across 3 years, with a median of $156390.0 in 2024.
- Annual changes were most pronounced in 2024 — Finished Goods declined 15.65% — and 2025, when it soared 74.99%.
- 60 Degrees Pharmaceuticals' Finished Goods stood at $187182.0 in 2023, then fell by 15.65% to $157881.0 in 2024, then soared by 31.87% to $208195.0 in 2025.
- Business Quant data shows SXTP's Finished Goods at $208195.0 in Q2 2025, $143161.0 in Q1 2025, and $157881.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 208,195.00 |
| Mar 31, 2025 | 143,161.00 |
| Dec 31, 2024 | 157,881.00 |
| Sep 30, 2024 | 84,449.00 |
| Jun 30, 2024 | 118,973.00 |
| Mar 31, 2024 | 156,390.00 |
| Dec 31, 2023 | 187,182.00 |